IPAH
Showing 1 - 25 of 56
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH
Recruiting
- Scleroderma
- Pulmonary Artery Hypertension
-
Baltimore, MarylandJohns Hopkins
Oct 20, 2022
Pulmonary Arterial Hypertension, Iron Deficiency Trial in China, Germany, United Kingdom (Saline, Ferinject or CosmoFer)
Completed
- Pulmonary Arterial Hypertension
- Iron Deficiency
- Saline
- Ferinject or CosmoFer
-
Beijing, China
- +4 more
Dec 13, 2021
Chronic Thrombo-embolic Pulmonary Hypertension: Classification
Completed
- Chronic Thromboembolic Pulmonary Hypertension
- Idiopathic Pulmonary Arterial Hypertension
-
Sheffield, South Yorkshire, United KingdomSheffield Teaching Hospitals NHS Foundation Trust
Jun 23, 2022
Pulmonary Hypertension, Ketonemia Trial in Aarhus (Hyperketonemia - use of ketone (3-OHB) infusion, Placebo - use of saline
Completed
- Pulmonary Hypertension
- Ketonemia
- Hyperketonemia - use of ketone (3-OHB) infusion
- Placebo - use of saline infusion
-
Aarhus, Region Midjylland, DenmarkDept. of cardiology, Aarhus University hospital Skejby,
Dec 1, 2021
ADAMTSL4 in Idiopathic Pulmonary Hypertension and CTEPH
Completed
- Pulmonary Hypertension
- drugs or BPA
-
Chongqing, Chongqing, Chinathe First Affiliated Hospital, Chongqing Medical University
Jul 26, 2022
Secondary Pulmonary Arterial Hypertension Trial run by the National Institutes of Health Clinical Center (CC) (Heart
Completed
- Secondary Pulmonary Arterial Hypertension
- Heart Catheterization
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With
Not yet recruiting
- Pulmonary Arterial Hypertension
- +3 more
- 129Xe Hyperpolarized
-
Durham, North CarolinaDuke University Medical Center
Oct 23, 2023
Pulmonary Arterial Hypertension
Recruiting
- Pulmonary Disease
- Pulmonary Hypertension
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial
Completed
- Pulmonary Arterial Hypertension
- hepcidin levels and BMPR2 expression
-
Heidelberg, GermanyCentre for Pulmonary Hypertension at the Thoraxklinik, Heidelber
Apr 28, 2021
Volatile Organic Compounds asBiomarker in Immune-mediated
Recruiting
- Pulmonary Arterial Hypertension
- +2 more
-
Maastricht, NetherlandsMaastricht University Medical Center
Sep 7, 2021
Pulmonary Arterial Hypertension (PAH) Trial in Los Angeles (Allogeneic Human Cardiosphere-Derived Stem Cells, Placebo)
Active, not recruiting
- Pulmonary Arterial Hypertension (PAH)
- Allogeneic Human Cardiosphere-Derived Stem Cells
- Placebo
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 7, 2022
StratosPHere (Non-interventional Study)
Completed
- Pulmonary Arterial Hypertension
- +3 more
-
Cambridge, England, United KingdomUniversity of Cambridge Heart and Lung Research Institute
Mar 2, 2023
Shigella Infection, Enterotoxigenic Escherichia Coli Infection Trial in Baltimore (strain CVD 1208S-122, Placebo)
Not yet recruiting
- Shigella Infection
- Enterotoxigenic Escherichia Coli Infection
- strain CVD 1208S-122
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore, University of Maryland School
Jul 26, 2022
Resilience in Pulmonary Arterial Hypertension and Genetically
Recruiting
- Idiopathic Pulmonary Arterial Hypertension
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 9, 2022
Shigellosis Trial in Dhaka (Tebipenem Pivoxil, Azithromycin, Ceftriaxon)
Recruiting
- Shigellosis
- Tebipenem Pivoxil
- +2 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Jan 18, 2023
Pulmonary Arterial Hypertension Trial in Pittsburgh (18F-FGLN PET Imaging, (18F)FPGLU)
Not yet recruiting
- Pulmonary Arterial Hypertension
- 18F-FGLN PET Imaging
- (18F)FPGLU
-
Pittsburgh, PennsylvaniaMontefiore Hospital Clinical and Translational Research Center
Jul 7, 2022
The Exercise Capacity and Quality of Life in IPAH and Secondary
Completed
- Hypertension, Pulmonary
-
Taipei, Zhongzheng Dist, TaiwanNational Taiwan University Hospital
Jul 10, 2018
Pathological Gambling Trial in Nantes (cognitive, emotional and clinical assessment)
Completed
- Pathological Gambling
- cognitive, emotional and clinical assessment
-
Nantes, FranceCHU de Nantes
Mar 29, 2021
Pulmonary Hypertension Using Cardiac Magnetic Resonance Images
Completed
- Pulmonary Hypertension
- 6MWT
- Cardiovascular Magnetic Resonance Imaging (CMRI)
-
Singapore, SingaporeNational Heart Centre Singapore
Aug 2, 2020
Pulmonary Arterial Hypertension, Deep Phenotyping, Idiopathic Pulmonary Arterial Hypertension Trial in Incheon (Deep
Unknown status
- Pulmonary Arterial Hypertension
- +3 more
- Deep phenotyping
-
Incheon, Korea, Republic ofDepartment of Cardiovascular Medicine, Gachon University, Gil Me
Apr 28, 2019
Pulmonary Arterial Hypertension Trial in Pittsburgh (Exercise Rehab)
Withdrawn
- Pulmonary Arterial Hypertension
- Exercise Rehab
-
Pittsburgh, PennsylvaniaDivision of Pulmonary, Allergy and Critical Care Medicine
Feb 15, 2022
Pulmonary Arterial Hypertension Trial in Glasgow City (Exercise therapy)
Completed
- Pulmonary Arterial Hypertension
- Exercise therapy
-
Glasgow City, United KingdomDr Martin Johnson
Aug 19, 2019
Idiopathic Pulmonary Arterial Hypertension Trial in London ((Pyr1)apelin-13, Saline)
Completed
- Idiopathic Pulmonary Arterial Hypertension
-
London, United Kingdom
- +1 more
Apr 12, 2019
Systemic Sclerosis, Pulmonary Hypertension Trial in Heidelberg (Ambrisentan, Placebo)
Completed
- Systemic Sclerosis
- Pulmonary Hypertension
- Ambrisentan
- Placebo
-
Heidelberg, GermanyThoraxclinic at the University of Heidelberg
Apr 17, 2020